Patents by Inventor Yongwoo Jang

Yongwoo Jang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF NURR1- AND PPARy-MEDIATED CONDITIONS
    Publication number: 20230190873
    Abstract: Provided herein are methods and compositions for treating a Nurr1-mediated and/or PPAR?-mediated condition. Also provided herein are methods and compositions for increasing Nurr1 or PPAR? activity and/or levels in a cell.
    Type: Application
    Filed: July 20, 2022
    Publication date: June 22, 2023
    Inventors: Kwang-Soo Kim, Yongwoo Jang, Chun-Hyung Kim
  • METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF NURR1- AND PPARy-MEDIATED CONDITIONS
    Publication number: 20200206309
    Abstract: Provided herein are methods and compositions for treating a Nurr1-mediated and/or PPAR-mediated condition. Also provided herein are methods and compositions for increasing Nurr1 or PPAR activity and/or levels in a cell.
    Type: Application
    Filed: July 27, 2018
    Publication date: July 2, 2020
    Inventors: Kwang-Soo Kim, Yongwoo Jang, Chun-Hyung Kim
  • METHOD OF IDENTIFYING AGENTS WHICH MODULATE THE ACTIVITY OF CALCIUM-ACTIVATED CHLORIDE CHANNEL
    Publication number: 20100209934
    Abstract: The present invention provides a method of identifying an agent which modulates an activity of a protein, wherein the protein is represented by the amino acid sequence of SEQ ID NO: 1 or has at least 90% amino acid sequence identity to SEQ ID NO: 1 and transports chloride ions across a cell membrane, comprising: (a) exposing cells which express the protein to the agent; and (b) measuring degree of chloride ion transport in the exposed cells, wherein a change in the degree of chloride ion transport compared to control cells, which express the protein but not exposed to the agent, is indicative of an agent capable of modulating an activity of the protein. The agents identified by this method can be used for the prevention or treatment of various diseases caused by the dysfunction of calcium activated chloride channel.
    Type: Application
    Filed: October 17, 2008
    Publication date: August 19, 2010
    Applicant: SNU R&DB FOUNDATION
    Inventors: Uhtaek Oh, Hawon Cho, Young Duk Yang, Min Ho Tak, Yongwoo Jang, Jae Yeon Koo, Si Young Cho, Yeon Su Jeong